ArticleBritish journal of cancer2009

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.

C Kahlert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.